Addex Therapeutics Ltd

Fr 0.02As of Sun 8 Nov 2026, 12:00 UTC
SWX:ADXNHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR (37.66%)
Div yield —
ROE (150.58%)
Biotechnology
Beta (5Y) 2.06
PE TTM —
TSR TTM (67.80%)
Mkt cap Fr 4.585M
ROIC (35.19%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 0.0262
26.08%
(38.97%)
Hold 10|0|4|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareFr
—
—
—
—
17.40%
25.95%
18.42%
18.01%
RevenueFr M
0.213
0.218
0.217
0.227
(1.66%)
(1.84%)
(0.55%)
5.25%
Peers (US$5.622M)
Cap (US$)
PE
59.55M
—
15.74M
—
5.651M
1.763x
Capital
TTM
5Y
10Y
Leveragex
1.188
0.408
0.234
EBIT/Intx
0.859
0.391
0.327
Own earn%
282.11
114.52
113.11
Sh yield%
36.38
27.59
26.39
Owners
Insiders/Inst%
11.98
81.59
Short interest%
4.43
SBC / revenue%
3.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
20–27
$1 testx
—
Incr. ROIC%
5